Eupraxia pharmaceuticals announces cfo succession

-  bruce cousins is retiring, and former cfo alex rothwell will assume the role victoria, bc , feb. 18, 2025 /prnewswire/ - eupraxia pharmaceuticals inc. ("eupraxia" or the "company") (nasdaq: eprx) (tsx: eprx), a clinical-stage biotechnology company, today announced that it has appointed alex rothwell as the company's new chief financial officer, effective immediately. bruce cousins, the company's outgoing cfo, is retiring and will remain in a consultant role in the near-term to ensure an orderly transition of the cfo responsibilities.
EPRX Ratings Summary
EPRX Quant Ranking